Build Your Comparison

Side-by-side financial analysis
NCRA logo
NCRA
LIXT logo
LIXT
KO logo
KO
PEP logo
PEP
ONCY logo
ONCY
Try popular comparisons:

Stock Comparison

NCRA vs LIXT vs KO vs PEP vs ONCY

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NCRA
Nocera, Inc.

Packaged Foods

Consumer DefensiveNASDAQ • TW
Market Cap$2M
5Y Perf.-96.3%
LIXT
Lixte Biotechnology Holdings, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$76M
5Y Perf.-77.0%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$342.09B
5Y Perf.+65.1%
PEP
PepsiCo, Inc.

Beverages - Non-Alcoholic

Consumer DefensiveNASDAQ • US
Market Cap$193.90B
5Y Perf.+3.9%
ONCY
Oncolytics Biotech Inc.

Biotechnology

HealthcareNASDAQ • CA
Market Cap$94M
5Y Perf.-66.6%

NCRA vs LIXT vs KO vs PEP vs ONCY — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NCRA logoNCRA
LIXT logoLIXT
KO logoKO
PEP logoPEP
ONCY logoONCY
IndustryPackaged FoodsBiotechnologyBeverages - Non-AlcoholicBeverages - Non-AlcoholicBiotechnology
Market Cap$2M$76M$342.09B$193.90B$94M
Revenue (TTM)$11M$0.00$49.28B$93.92B$0.00
Net Income (TTM)$-4M$-7M$13.70B$8.24B$-35M
Gross Margin1.4%61.7%54.1%
Operating Margin-25.2%29.3%12.2%
Forward P/E24.3x16.4x
Total Debt$7M$664K$45.49B$49.90B$773K
Cash & Equiv.$8M$5M$10.27B$9.16B$7M

NCRA vs LIXT vs KO vs PEP vs ONCYLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NCRA
LIXT
KO
PEP
ONCY
StockJan 21Jun 26Return
Nocera, Inc. (NCRA)1003.7-96.3%
Lixte Biotechnology… (LIXT)10023.0-77.0%
The Coca-Cola Compa… (KO)100165.1+65.1%
PepsiCo, Inc. (PEP)100103.9+3.9%
Oncolytics Biotech … (ONCY)10033.4-66.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: NCRA vs LIXT vs KO vs PEP vs ONCY

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LIXT leads in 3 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. The Coca-Cola Company is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. PEP also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇LIXT emerged as the overall leader. Track its performance:
NCRA
Nocera, Inc.
The Consumer Defensive Pick

NCRA lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: consumer defensive exposure
LIXT
Lixte Biotechnology Holdings, Inc.
The Defensive Pick

LIXT carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.

  • Lower volatility, beta 1.19, Low D/E 6.1%, current ratio 3.88x
  • Beta 1.19, current ratio 3.88x
  • 152.8% revenue growth vs ONCY's -65.0%
  • Beta 1.19 vs NCRA's 1.68, lower leverage
Best for: sleep-well-at-night and defensive
KO
The Coca-Cola Company
The Growth Play

KO is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.

  • Rev growth 1.9%, EPS growth 23.6%, 3Y rev CAGR 3.7%
  • 112.9% 10Y total return vs PEP's 80.6%
  • PEG 2.18 vs PEP's 5.02
  • 27.8% margin vs NCRA's -34.0%
Best for: growth exposure and long-term compounding
PEP
PepsiCo, Inc.
The Income Pick

PEP ranks third and is worth considering specifically for income & stability.

  • Dividend streak 54 yrs, beta -0.09, yield 3.9%
  • Better valuation composite
  • 3.9% yield, 54-year raise streak, vs KO's 2.6%, (3 stocks pay no dividend)
Best for: income & stability
ONCY
Oncolytics Biotech Inc.
The Healthcare Pick

Among these 5 stocks, ONCY doesn't own a clear edge in any measured category.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthLIXT logoLIXT152.8% revenue growth vs ONCY's -65.0%
ValuePEP logoPEPBetter valuation composite
Quality / MarginsKO logoKO27.8% margin vs NCRA's -34.0%
Stability / SafetyLIXT logoLIXTBeta 1.19 vs NCRA's 1.68, lower leverage
DividendsPEP logoPEP3.9% yield, 54-year raise streak, vs KO's 2.6%, (3 stocks pay no dividend)
Momentum (1Y)LIXT logoLIXT+407.2% vs NCRA's -83.7%
Efficiency (ROA)KO logoKO13.1% ROA vs ONCY's -275.4%

NCRA vs LIXT vs KO vs PEP vs ONCY — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NCRANocera, Inc.

Segment breakdown not available.

LIXTLixte Biotechnology Holdings, Inc.

Segment breakdown not available.

KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B
PEPPepsiCo, Inc.

Segment breakdown not available.

ONCYOncolytics Biotech Inc.

Segment breakdown not available.

NCRA vs LIXT vs KO vs PEP vs ONCY — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLKOLAGGINGONCY

Income & Cash Flow (Last 12 Months)

KO leads this category, winning 5 of 6 comparable metrics.

PEP and ONCY operate at a comparable scale, with $93.9B and $0 in trailing revenue. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to NCRA's -34.0%. On growth, KO holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricNCRA logoNCRANocera, Inc.LIXT logoLIXTLixte Biotechnolo…KO logoKOThe Coca-Cola Com…PEP logoPEPPepsiCo, Inc.ONCY logoONCYOncolytics Biotec…
RevenueTrailing 12 months$11M$0$49.3B$93.9B$0
EBITDAEarnings before interest/tax-$3M-$7M$15.5B$14.3B-$31M
Net IncomeAfter-tax profit-$4M-$7M$13.7B$8.2B-$35M
Free Cash FlowCash after capex-$3M-$4M$12.6B$7.7B-$29M
Gross MarginGross profit ÷ Revenue+1.4%+61.7%+54.1%
Operating MarginEBIT ÷ Revenue-25.2%+29.3%+12.2%
Net MarginNet income ÷ Revenue-34.0%+27.8%+8.8%
FCF MarginFCF ÷ Revenue-26.9%+25.5%+8.2%
Rev. Growth (YoY)Latest quarter vs prior year-49.8%+12.1%+5.6%
EPS Growth (YoY)Latest quarter vs prior year-3.9%+37.9%+18.2%+66.7%-39.2%
KO leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

PEP leads this category, winning 3 of 7 comparable metrics.

At 23.6x trailing earnings, PEP trades at a 10% valuation discount to KO's 26.1x P/E. Adjusting for growth (PEG ratio), KO offers better value at 2.34x vs PEP's 7.25x — a lower PEG means you pay less per unit of expected earnings growth.

MetricNCRA logoNCRANocera, Inc.LIXT logoLIXTLixte Biotechnolo…KO logoKOThe Coca-Cola Com…PEP logoPEPPepsiCo, Inc.ONCY logoONCYOncolytics Biotec…
Market CapShares × price$2M$76M$342.1B$193.9B$94M
Enterprise ValueMkt cap + debt − cash$2M$72M$377.3B$234.6B$89M
Trailing P/EPrice ÷ TTM EPS-0.84x-5.56x26.14x23.65x-2.83x
Forward P/EPrice ÷ next-FY EPS est.24.31x16.39x
PEG RatioP/E ÷ EPS growth rate2.34x7.25x
EV / EBITDAEnterprise value multiple25.47x16.41x
Price / SalesMarket cap ÷ Revenue0.22x7.14x2.06x
Price / BookPrice ÷ Book value/share1.09x30.91x10.00x9.47x
Price / FCFMarket cap ÷ FCF64.59x25.27x
PEP leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

KO leads this category, winning 6 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-102 for ONCY. LIXT carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to NCRA's 3.31x. On the Piotroski fundamental quality scale (0–9), KO scores 7/9 vs ONCY's 1/9, reflecting strong financial health.

MetricNCRA logoNCRANocera, Inc.LIXT logoLIXTLixte Biotechnolo…KO logoKOThe Coca-Cola Com…PEP logoPEPPepsiCo, Inc.ONCY logoONCYOncolytics Biotec…
ROE (TTM)Return on equity-132.0%-113.2%+41.1%+40.1%-102.5%
ROA (TTM)Return on assets-52.5%-96.3%+13.1%+7.7%-2.8%
ROICReturn on invested capital-70.0%-121.5%+15.8%+14.9%
ROCEReturn on capital employed-35.9%-83.5%+17.3%+16.1%-5.1%
Piotroski ScoreFundamental quality 0–934751
Debt / EquityFinancial leverage3.31x0.06x1.33x2.43x
Net DebtTotal debt minus cash-$697,307-$4M$35.2B$40.7B-$6M
Cash & Equiv.Liquid assets$8M$5M$10.3B$9.2B$7M
Total DebtShort + long-term debt$7M$664,491$45.5B$49.9B$772,509
Interest CoverageEBIT ÷ Interest expense-1217.29x10.70x10.34x
KO leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

KO leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in KO five years ago would be worth $15,855 today (with dividends reinvested), compared to $343 for NCRA. Over the past 12 months, LIXT leads with a +407.2% total return vs NCRA's -83.7%. The 3-year compound annual growth rate (CAGR) favors KO at 12.0% vs NCRA's -51.6% — a key indicator of consistent wealth creation.

MetricNCRA logoNCRANocera, Inc.LIXT logoLIXTLixte Biotechnolo…KO logoKOThe Coca-Cola Com…PEP logoPEPPepsiCo, Inc.ONCY logoONCYOncolytics Biotec…
YTD ReturnYear-to-date-80.3%+82.3%+15.8%+1.8%-14.7%
1-Year ReturnPast 12 months-83.7%+407.2%+15.0%+13.7%+151.3%
3-Year ReturnCumulative with dividends-88.7%+5.6%+40.5%-14.1%-49.0%
5-Year ReturnCumulative with dividends-96.6%-77.3%+58.5%+13.3%-72.0%
10-Year ReturnCumulative with dividends-97.4%-22.2%+112.9%+80.6%-79.6%
CAGR (3Y)Annualised 3-year return-51.6%+1.8%+12.0%-4.9%-20.1%
KO leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

KO leads this category, winning 2 of 2 comparable metrics.

KO is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than NCRA's 1.68 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 96.1% from its 52-week high vs NCRA's 7.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNCRA logoNCRANocera, Inc.LIXT logoLIXTLixte Biotechnolo…KO logoKOThe Coca-Cola Com…PEP logoPEPPepsiCo, Inc.ONCY logoONCYOncolytics Biotec…
Beta (5Y)Sensitivity to S&P 5001.68x1.19x-0.15x-0.09x1.24x
52-Week HighHighest price in past year$2.40$7.50$82.66$171.48$1.51
52-Week LowLowest price in past year$0.16$0.64$65.35$127.60$0.33
% of 52W HighCurrent price vs 52-week peak+7.0%+93.3%+96.1%+82.7%+55.4%
RSI (14)Momentum oscillator 0–10040.869.837.733.746.2
Avg Volume (50D)Average daily shares traded7.2M89K12.7M5.8M1.3M
KO leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — KO and PEP each lead in 1 of 2 comparable metrics.

Analyst consensus: KO as "Buy", PEP as "Hold", ONCY as "Buy". Consensus price targets imply 21.1% upside for PEP (target: $172) vs 8.6% for KO (target: $86). For income investors, PEP offers the higher dividend yield at 3.93% vs KO's 2.56%.

MetricNCRA logoNCRANocera, Inc.LIXT logoLIXTLixte Biotechnolo…KO logoKOThe Coca-Cola Com…PEP logoPEPPepsiCo, Inc.ONCY logoONCYOncolytics Biotec…
Analyst RatingConsensus buy/hold/sellBuyHoldBuy
Price TargetConsensus 12-month target$86.29$171.86
# AnalystsCovering analysts484510
Dividend YieldAnnual dividend ÷ price+2.6%+3.9%
Dividend StreakConsecutive years of raises05654
Dividend / ShareAnnual DPS$2.04$5.57
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.2%+0.5%0.0%
Evenly matched — KO and PEP each lead in 1 of 2 comparable metrics.
Key Takeaway

KO leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PEP leads in 1 (Valuation Metrics). 1 tied.

Best OverallThe Coca-Cola Company (KO)Leads 4 of 6 categories
Loading custom metrics...

NCRA vs LIXT vs KO vs PEP vs ONCY: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is NCRA or LIXT or KO or PEP or ONCY a better buy right now?

For growth investors, PepsiCo, Inc.

(PEP) is the stronger pick with 2. 3% revenue growth year-over-year, versus -35. 2% for Nocera, Inc. (NCRA). PepsiCo, Inc. (PEP) offers the better valuation at 23. 6x trailing P/E (16. 4x forward), making it the more compelling value choice. Analysts rate The Coca-Cola Company (KO) a "Buy" — based on 48 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — NCRA or LIXT or KO or PEP or ONCY?

On trailing P/E, PepsiCo, Inc.

(PEP) is the cheapest at 23. 6x versus The Coca-Cola Company at 26. 1x. On forward P/E, PepsiCo, Inc. is actually cheaper at 16. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Coca-Cola Company wins at 2. 18x versus PepsiCo, Inc. 's 5. 02x.

03

Which is the better long-term investment — NCRA or LIXT or KO or PEP or ONCY?

Over the past 5 years, The Coca-Cola Company (KO) delivered a total return of +58.

5%, compared to -96. 6% for Nocera, Inc. (NCRA). Over 10 years, the gap is even starker: KO returned +112. 9% versus NCRA's -97. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — NCRA or LIXT or KO or PEP or ONCY?

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

15β versus Nocera, Inc. 's 1. 68β — meaning NCRA is approximately -1234% more volatile than KO relative to the S&P 500. On balance sheet safety, Lixte Biotechnology Holdings, Inc. (LIXT) carries a lower debt/equity ratio of 6% versus 3% for Nocera, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — NCRA or LIXT or KO or PEP or ONCY?

By revenue growth (latest reported year), PepsiCo, Inc.

(PEP) is pulling ahead at 2. 3% versus -35. 2% for Nocera, Inc. (NCRA). On earnings-per-share growth, the picture is similar: The Coca-Cola Company grew EPS 23. 6% year-over-year, compared to -13. 7% for PepsiCo, Inc.. Over a 3-year CAGR, KO leads at 3. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — NCRA or LIXT or KO or PEP or ONCY?

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus -25. 7% for Nocera, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus -22. 3% for NCRA. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is NCRA or LIXT or KO or PEP or ONCY more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, The Coca-Cola Company (KO) is the more undervalued stock at a PEG of 2. 18x versus PepsiCo, Inc. 's 5. 02x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, PepsiCo, Inc. (PEP) trades at 16. 4x forward P/E versus 24. 3x for The Coca-Cola Company — 7. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PEP: 21. 1% to $171. 86.

08

Which pays a better dividend — NCRA or LIXT or KO or PEP or ONCY?

In this comparison, PEP (3.

9% yield), KO (2. 6% yield) pay a dividend. NCRA, LIXT, ONCY do not pay a meaningful dividend and should not be held primarily for income.

09

Is NCRA or LIXT or KO or PEP or ONCY better for a retirement portfolio?

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

15), 2. 6% yield, +112. 9% 10Y return). Nocera, Inc. (NCRA) carries a higher beta of 1. 68 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KO: +112. 9%, NCRA: -97. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between NCRA and LIXT and KO and PEP and ONCY?

These companies operate in different sectors (NCRA (Consumer Defensive) and LIXT (Healthcare) and KO (Consumer Defensive) and PEP (Consumer Defensive) and ONCY (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: NCRA is a small-cap quality compounder stock; LIXT is a small-cap quality compounder stock; KO is a large-cap quality compounder stock; PEP is a mid-cap income-oriented stock; ONCY is a small-cap quality compounder stock. KO, PEP pay a dividend while NCRA, LIXT, ONCY do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.